+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Iohexol Injection Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129150
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare executives navigating the advanced diagnostic imaging sector will recognize the increasing importance of iohexol injection amid rising clinical precision demands and evolving global regulatory environments. This executive summary outlines the changing landscape and key success strategies, equipping decision-makers to strengthen their positioning in the competitive iohexol injection market.

Market Snapshot: Iohexol Injection Market Growth and Dynamics

The iohexol injection market is experiencing sustained expansion, driven by the acceleration of high-precision imaging procedures across diverse medical domains. Increased awareness, innovations in contrast agent purity, and rapidly updating safety standards have made iohexol injection a cornerstone in radiology and diagnostic imaging centers worldwide. Decision-makers with stakes in research, product development, or commercial functions now face a rapidly evolving environment shaped by technology, end-user dynamics, and supply chain shifts.

Scope & Segmentation of the Iohexol Injection Market

Comprehensive evaluation of the market covers the following segments and geographic regions:

  • Application: Angiography, Computed Tomography, Urography
  • Route of Administration: Intra-Arterial, Intrathecal, Intravenous
  • End User: Ambulatory Surgical Centers, Clinics, Diagnostic Imaging Centers, Hospitals
  • Product Type: Prefilled Syringe, Vial
  • Concentration: 300 mg I/mL, 350 mg I/mL, 370 mg I/mL
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Italy, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Notable Companies: GE HealthCare Technologies Inc., Bayer AG, Bracco Imaging S.p.A., Guerbet S.A., Shanghai Pharmaceuticals Holding Co., Ltd., and others

Key Takeaways for Decision-Makers

  • Iohexol injection remains a preferred non-ionic, low-osmolar contrast agent, valued for reduced adverse event profile and superior diagnostic clarity.
  • Recent technological advances include nanofiltration for consistent purity, integration with AI-powered dosing, and next-generation osmolarity refinements.
  • Segment relevance evolves as workflow efficiency in ambulatory and acute care environments increases; prefilled syringes and vials address distinct operational needs.
  • Regional procurement strategies are diversifying, with vendors balancing cost containment against quality and compliance mandates, reflecting increasing supply chain complexity.
  • Collaborative industry partnerships with imaging equipment manufacturers foster data-driven product enhancements and streamline procedures for end users.
  • Competitive edge is maintained through investment in proprietary technologies, robust patent management, and agile responses to regulatory shifts across markets.

Tariff Impact on Iohexol Injection Supply Chains

With the introduction of United States tariff measures in 2025, global supply structures are adapting. Import duties on raw materials have prompted manufacturers to reassess partnerships and diversify sourcing. Some value chain members absorb cost fluctuations through enhanced packaging efficiencies or long-term procurement contracts, while domestic producers benefit from tariff-driven incentives and greater local production capacity. Multinational companies are evaluating investments in US-based facilities to remain competitive amid evolving economic policies.

Iohexol Injection Market: Technological Advancements

Segment expansion and adoption are influenced by AI-enhanced imaging software, which supports optimized contrast dosing and shorter procedures. Secondary keywords featured in this section include clinical innovation and strategic collaborations, each shaping differentiation in an increasingly segmented landscape. Advances in formulation purity and new delivery platforms are improving compliance with safety protocols and supporting broader use in minimally invasive diagnostic settings.

Methodology & Data Sources

This report synthesizes insights from primary interviews with imaging specialists, procurement executives, and regulatory experts. Secondary sources include peer-reviewed literature, regulatory databases, and industry white papers. Analytical frameworks ensure data credibility across global market segments.

Why This Report Matters for Market Leaders

  • Gain actionable intelligence for product portfolio differentiation and resource allocation across regional and segment lines, tailored for evolving end-user expectations.
  • Identify tariff risks, regulatory updates, and supply chain challenges, guiding budgetary and procurement decisions for sustained operations.
  • Leverage detailed competitive and segmentation analysis to optimize strategic planning and collaborative growth initiatives.

Conclusion: Strategic Outlook

As the iohexol injection market adapts to innovation, regulation, and shifting cost dynamics, organizations equipped with granular, data-driven insights are best prepared to capture growth opportunities. Flexible planning and collaborative approaches remain essential in this competitive healthcare segment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of Iohexol injection in CT and angiography procedures driven by advanced diagnostic needs
5.2. Expansion of generic Iohexol formulations intensifying competition and driving price sensitivity in key markets
5.3. Growing demand for low-osmolar Iohexol injections to reduce adverse reactions in high-risk patient groups
5.4. Strategic partnerships between contrast media manufacturers and imaging service providers to enhance market reach
5.5. Regulatory approvals for novel Iohexol formulations boosting access in emerging economies and specialty clinics
5.6. Rising utilization of Iohexol injection in COVID-19 imaging protocols fueling short-term volume growth and research initiatives
5.7. Supply chain resilience measures adopted by manufacturers to mitigate raw material shortages and logistical disruptions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Iohexol Injection Market, by Application
8.1. Introduction
8.2. Angiography
8.3. Computed Tomography
8.4. Urography
9. Iohexol Injection Market, by Route Of Administration
9.1. Introduction
9.2. Intra-Arterial
9.3. Intrathecal
9.4. Intravenous
10. Iohexol Injection Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Imaging Centers
10.5. Hospitals
11. Iohexol Injection Market, by Product Type
11.1. Introduction
11.2. Prefilled Syringe
11.3. Vial
12. Iohexol Injection Market, by Concentration
12.1. Introduction
12.2. 300 mg I/mL
12.3. 350 mg I/mL
12.4. 370 mg I/mL
13. Iohexol Injection Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacy
13.3. Online Pharmacy
13.4. Retail Pharmacy
14. Americas Iohexol Injection Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Iohexol Injection Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Iohexol Injection Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GE HealthCare Technologies Inc.
17.3.2. Bayer AG
17.3.3. Bracco Imaging S.p.A.
17.3.4. Guerbet S.A.
17.3.5. Shanghai Pharmaceuticals Holding Co., Ltd.
17.3.6. Jiangsu Hengrui Medicine Co., Ltd.
17.3.7. Shenzhen Salubris Pharmaceutical Co., Ltd.
17.3.8. Sagent Pharmaceuticals, Inc.
17.3.9. Hikma Pharmaceuticals PLC
17.3.10. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
18. ResearchAI19. ResearchStatistics20. ResearchContacts21. ResearchArticles22. Appendix
List of Figures
FIGURE 1. IOHEXOL INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IOHEXOL INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IOHEXOL INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IOHEXOL INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. IOHEXOL INJECTION MARKET: RESEARCHAI
FIGURE 28. IOHEXOL INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 29. IOHEXOL INJECTION MARKET: RESEARCHCONTACTS
FIGURE 30. IOHEXOL INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IOHEXOL INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IOHEXOL INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IOHEXOL INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ANGIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY UROGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY UROGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY INTRA-ARTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY INTRA-ARTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY INTRATHECAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY 300 MG I/ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY 300 MG I/ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY 350 MG I/ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY 350 MG I/ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY 370 MG I/ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY 370 MG I/ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IOHEXOL INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES IOHEXOL INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. CANADA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. CANADA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. MEXICO IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. MEXICO IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA IOHEXOL INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. GERMANY IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. GERMANY IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. GERMANY IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. GERMANY IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. GERMANY IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. GERMANY IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. GERMANY IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. GERMANY IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. FRANCE IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. FRANCE IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. FRANCE IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. FRANCE IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. FRANCE IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. FRANCE IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. FRANCE IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. FRANCE IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. ITALY IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ITALY IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ITALY IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. ITALY IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. ITALY IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ITALY IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ITALY IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. ITALY IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. ITALY IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ITALY IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SPAIN IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. SPAIN IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. SPAIN IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. SPAIN IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. SPAIN IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. SPAIN IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. SPAIN IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SPAIN IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. DENMARK IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. DENMARK IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. DENMARK IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. DENMARK IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. DENMARK IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. DENMARK IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. DENMARK IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. QATAR IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. QATAR IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. QATAR IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. QATAR IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. QATAR IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. QATAR IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. QATAR IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. QATAR IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. QATAR IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 289. QATAR IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. QATAR IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. FINLAND IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. FINLAND IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. FINLAND IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. FINLAND IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. FINLAND IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. FINLAND IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. FINLAND IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FINLAND IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. EGYPT IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. EGYPT IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. EGYPT IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. EGYPT IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. EGYPT IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. EGYPT IOHEXOL INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. EGYPT IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. EGYPT IOHEXOL INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. EGYPT IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 336. EGYPT IOHEXOL INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 337. EGYPT IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. EGYPT IOHEXOL INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. TURKEY IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. TURKEY IOHEXOL INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. TURKEY IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. TURKEY IOHEXOL INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. TURKEY IOHEXOL INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. TURKEY IOHEXOL IN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Iohexol Injection Market report include:
  • GE HealthCare Technologies Inc.
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Guerbet S.A.
  • Shanghai Pharmaceuticals Holding Co., Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Shenzhen Salubris Pharmaceutical Co., Ltd.
  • Sagent Pharmaceuticals, Inc.
  • Hikma Pharmaceuticals PLC
  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd.